Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology.
Bias
Financial conflict of interest
OncLive
Oncology news
Spin
Sunshine act
Targeted Oncology
Journal
Journal of cancer policy
ISSN: 2213-5383
Titre abrégé: J Cancer Policy
Pays: England
ID NLM: 101639933
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
31
10
2022
revised:
28
01
2023
accepted:
07
02
2023
medline:
30
5
2023
pubmed:
12
2
2023
entrez:
11
2
2023
Statut:
ppublish
Résumé
Oncology media websites such as Oncology Live (OncLive) and Targeted Oncology (TargetedOnc) play an important role in the dissemination of oncology news to patients and clinicians; however, the quality of the content on these websites has not been assessed. Our study aimed to analyze content from these websites and assess financial conflicts of interest (FCOI) amongst speakers interviewed on these websites. Articles published on OncLive and TargetedOnc during October 2021, were prospectively captured and analyzed. The primary outcome of our study was the quality of oncology news reporting in OncLive and TargetedOnc. We assessed the FCOI amongst speakers using data from Open Payments. We examined 196 articles (OncLive 108, TargetedOnc 88). Limitations of cited research were reported in 7% (7/105) of OncLive and zero TargetedOnc articles. Benefit and risks in absolute numbers were reported in 28% (28/99) of OncLive and 16% (7/45) of TargetedOnc articles. Independent experts were quoted in 47% (51/108) and 51% (44/86) of the OncLive and TargetedOnc articles, respectively (Table 3). Pharmaceutical executives were quoted in 18% (20/108) and 11% (10/88) of OncLive and TargetedOnc articles, respectively. No FCOI disclosures were listed or reported for any articles. The mean general payment received from industry by United States physicians was $63,861 in 2019 and $39,639 in 2020. Our study demonstrates low quality and potentially biased reporting of oncology news on OncLive and TargetedOnc. Careful safeguards, oversight and reporting of relevant FCOI are needed to maintain the quality and transparency of content being provided.
Identifiants
pubmed: 36773798
pii: S2213-5383(23)00028-0
doi: 10.1016/j.jcpo.2023.100411
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100411Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest Disclosures Dr. Booth is supported as the Canada Research Chair in Population Cancer Care. He has no other disclosures. Dr. Prasad reports research funding from Arnold Ventures; royalties from Johns Hopkins Press, MedPage, YouTube, and Substack; consulting from Optum Health; and other payments for his podcast Plenary Session podcast which has Patreon subscribers. All other authors report no funding or conflicts of interest.